We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AVCN market cap is 27.73M. The company's latest EPS is CAD -0.1166 and P/E is -3.17.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 272k | 2.89M | 4.88M | 5.81M | 16.79M |
| Operating Income | -23.22M | -29.34M | -15.41M | -11.15M | -7.95M |
| Net Income | -21.07M | -32.86M | -16.78M | -14.74M | -8.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 45.16M | 30.16M | 22.3M | 17.62M | 21.97M |
| Total Liabilities | 15.29M | 16.25M | 15.39M | 14.16M | 14M |
| Total Equity | 29.88M | 13.91M | 6.91M | 3.46M | 7.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -19.45M | -13.97M | -11.66M | -7.44M | -1.4M |
| Investing | -7.49M | -2.71M | 761k | 810k | -3.05M |
| Financing | 27.31M | 17.39M | 10.06M | 9.9M | 3.55M |
| Market Cap | 27.73M |
| Price to Earnings Ratio | -3.17 |
| Price to Sales Ratio | 1.65 |
| Price to Cash Ratio | 57.81 |
| Price to Book Ratio | 3.48 |
| Dividend Yield | - |
| Shares Outstanding | 74.95M |
| Average Volume (1 week) | 279.37k |
| Average Volume (1 Month) | 280.09k |
| 52 Week Change | -23.71% |
| 52 Week High | 0.60 |
| 52 Week Low | 0.20 |
| Spread (Intraday) | 0.01 (1.35%) |
| Company Name | Avicanna Inc |
| Address |
480 university avenue toronto, ontario M5G 1V2 |
| Website | https://www.avicanna.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
